abstract |
FIELD: biotechnology.SUBSTANCE: invention relates to the field of biotechnology, more specifically to obtaining immunogenic mutant toxins Clostridium difficile; it can be used in medicine for the treatment of C. difficile infection in a mammal. A mutant toxin C. difficile containing amino acid sequence SEQ ID NO: 6, wherein methionine residue in the position 1 is probably absent, a nucleic acid encoding it, a composition containing it, antibodies to it, and a composition containing the specified antibodies are proposed.EFFECT: invention allows inducing effectively neutralizing antibodies against the toxin B C. difficile.33 cl, 25 dwg, 61 tbl, 45 ex |